TP63 and colorectal carcinoma: The differential seroreactivity was assessed by the luminescence HaloTag-bead assays as well as by the electrochemical biosensing strategy, which confirmed by two different approaches the diagnostic ability of specific p53 and p63 proteoforms in CRC.